O-GlcNAcylation regulates EZH2 protein stability and function

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 4, 2014, Pages 1355-1360

  Chu, Chi Shuen ^a   Lo, Pei Wen ^a,b   Yeh, Yi Hsien ^a   Hsu, Pang Hung ^c,d   Peng, Shih Huan ^a   Teng, Yu Ching ^a   Kang, Ming Lun ^a   Wong, Chi Huey ^a   Juan, Li Jung ^a  

^a GENOMICS RESEARCH CENTER   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN OCEAN UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; N ACETYLGLUCOSAMINE; O ACETYLGLUCOSAMINE; TRANSCRIPTION FACTOR EZH2; UNCLASSIFIED DRUG;

ACYLATION; ARTICLE; CANCER CELL; CONTROLLED STUDY; DOWN REGULATION; HISTONE MODIFICATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; METHYLATION; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEDIMENTATION; TRANSCRIPTION INITIATION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ACETYLGLUCOSAMINE; DNA METHYLATION; DOWN-REGULATION; GENE KNOCKDOWN TECHNIQUES; GENES, TUMOR SUPPRESSOR; HUMANS; N-ACETYLGLUCOSAMINYLTRANSFERASES; POLYCOMB REPRESSIVE COMPLEX 2; PROTEIN STABILITY;

EID: 84893414724     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1323226111     Document Type: Article

References (59)

1. Torres CR, Hart GW (1984) Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. J Biol Chem 259(5):3308-3317.
2. Holt GD, Hart GW (1986) The subcellular distribution of terminal N-acetylglucosamine moieties. Localization of a novel protein-saccharide linkage, O-linked GlcNAc. J Biol Chem 261(17):8049-8057.
3. Haltiwanger RS, Holt GD, Hart GW (1990) Enzymatic addition of O-GlcNAc to nuclear and cytoplasmic proteins. Identification of a uridine diphospho-N-acetylglucosamine: peptide beta-N-acetylglucosaminyltransferase. J Biol Chem 265(5):2563-2568.
4. Kreppel LK, Blomberg MA, Hart GW (1997) Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats. J Biol Chem 272(14):9308-9315.
5. Dong DL, Hart GW (1994) Purification and characterization of an O-GlcNAc selective N-acetyl-beta-D-glucosaminidase from rat spleen cytosol. J Biol Chem 269(30):19321-19330.
6. Vocadlo DJ (2012) O-GlcNAc processing enzymes: catalytic mechanisms, substrate specificity, and enzyme regulation. Curr Opin Chem Biol 16(5-6):488-497.
7. Simanek EE, et al. (1998) Glycosylation of threonine of the repeating unit of RNA polymerase II with beta-linked N-acetylglucosame leads to a turnlike structure. J Am Chem Soc 120(45):11567-11575.
8. Hart GW, Slawson C, Ramirez-Correa G, Lagerlof O (2011) Cross talk between O-GlcNAcylation and phosphorylation: Roles in signaling, transcription, and chronic disease. Annu Rev Biochem 80:825-858.
9. Yang X, et al. (2001) O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability. Proc Natl Acad Sci USA 98(12):6611-6616.
10. Gewinner C, et al. (2004) The coactivator of transcription CREB-binding protein interacts preferentially with the glycosylated form of Stat5. J Biol Chem 279(5):3563-3572.
11. Yang WH, et al. (2006) Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability. Nat Cell Biol 8(10):1074-1083.
12. Jang H, et al. (2012) O-GlcNAc regulates pluripotency and reprogramming by directly acting on core components of the pluripotency network. Cell Stem Cell 11(1):62-74.
13. Bond MR, Hanover JA (2013) O-GlcNAc cycling: A link between metabolism and chronic disease. Annu Rev Nutr 33:205-229.
14. Hanover JA, Krause MW, Love DC (2012) Bittersweet memories: Linking metabolism to epigenetics through O-GlcNAcylation. Nat Rev Mol Cell Biol 13(5):312-321.
15. Slawson C, Hart GW (2011) O-GlcNAc signalling: Implications for cancer cell biology. Nat Rev Cancer 11(9):678-684.
16. Ozcan S, Andrali SS, Cantrell JE (2010) Modulation of transcription factor function by O-GlcNAc modification. Biochim Biophys Acta 1799(5-6):353-364.
17. Sakabe K, Wang Z, Hart GW (2010) Beta-N-acetylglucosamine (O-GlcNAc) is part of the histone code. Proc Natl Acad Sci USA 107(46):19915-19920.
18. Fujiki R, et al. (2011) GlcNAcylation of histone H2B facilitates its monoubiquitination. Nature 480(7378):557-560.
19. Zhang S, Roche K, Nasheuer HP, Lowndes NF (2011) Modification of histones by sugar ?-N-acetylglucosamine (GlcNAc) occurs on multiple residues, including histone H3 serine 10, and is cell cycle-regulated. J Biol Chem 286(43):37483-37495.
20. Fong JJ, et al. (2012) ?-N-Acetylglucosamine (O-GlcNAc) is a novel regulator of mitosisspecific phosphorylations on histone H3. J Biol Chem 287(15):12195-12203.
21. Yang X, Zhang F, Kudlow JE (2002) Recruitment of O-GlcNAc transferase to promoters by corepressor mSin3A: Coupling protein O-GlcNAcylation to transcriptional repression. Cell 110(1):69-80.
22. Chen Q, Chen Y, Bian C, Fujiki R, Yu X (2013) TET2 promotes histone O-GlcNAcylation during gene transcription. Nature 493(7433):561-564.
23. Vella P, et al. (2013) Tet proteins connect the O-linked N-acetylglucosamine transferase Ogt to chromatin in embryonic stem cells. Mol Cell 49(4):645-656.
24. Deplus R, et al. (2013) TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS. EMBO J 32(5):645-655.
25. Shi FT, et al. (2013) Ten-eleven translocation 1 (Tet1) is regulated by O-linked Nacetylglucosamine transferase (Ogt) for target gene repression in mouse embryonic stem cells. J Biol Chem 288(29):20776-20784.
26. Cao R, et al. (2002) Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 298(5595):1039-1043.
27. Kuzmichev A, Nishioka K, Erdjument-Bromage H, Tempst P, Reinberg D (2002) Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein. Genes Dev 16(22):2893-2905.
28. Czermin B, et al. (2002) Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal Polycomb sites. Cell 111(2): 185-196.
29. Müller J, et al. (2002) Histone methyltransferase activity of a Drosophila Polycomb group repressor complex. Cell 111(2):197-208.
30. Cao R, Zhang Y (2004) The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3. Curr Opin Genet Dev 14(2):155-164.
31. Chang CJ, Hung MC (2012) The role of EZH2 in tumour progression. Br J Cancer 106(2): 243-247.
32. Knutson SK, et al. (2013) Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2. Proc Natl Acad Sci USA 110(19):7922-7927.
33. Knutson SK, et al. (2012) A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells. Nat Chem Biol 8(11):890-896.
34. Gambetta MC, Oktaba K, Müller J (2009) Essential role of the glycosyltransferase sxc/ Ogt in polycomb repression. Science 325(5936):93-96.
35. Sinclair DA, et al. (2009) Drosophila O-GlcNAc transferase (OGT) is encoded by the Polycomb group (PcG) gene, super sex combs (sxc). Proc Natl Acad Sci USA 106(32): 13427-13432.
36. Love DC, et al. (2010) Dynamic O-GlcNAc cycling at promoters of Caenorhabditis elegans genes regulating longevity, stress, and immunity. Proc Natl Acad Sci USA 107(16):7413-7418.
37. Myers SA, Panning B, Burlingame AL (2011) Polycomb repressive complex 2 is necessary for the normal site-specific O-GlcNAc distribution in mouse embryonic stem cells. Proc Natl Acad Sci USA 108(23):9490-9495.
38. Hübner MR, Spector DL (2010) Role of H3K27 demethylases Jmjd3 and UTX in transcriptional regulation. Cold Spring Harb Symp Quant Biol 75:43-49.
39. Bracken AP, Dietrich N, Pasini D, Hansen KH, Helin K (2006) Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev 20(9): 1123-1136.
40. Bracken AP, et al. (2003) EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J 22(20):5323-5335.
41. Montgomery ND, et al. (2005) The murine polycomb group protein Eed is required for global histone H3 lysine-27 methylation. Curr Biol 15(10):942-947.
42. Laughlin ST, Bertozzi CR (2007) Metabolic labeling of glycans with azido sugars and subsequent glycan-profiling and visualization via Staudinger ligation. Nat Protoc 2(11):2930-2944.
43. Fardini Y, Dehennaut V, Lefebvre T, Issad T (2013) O-GlcNAcylation: A new cancer hallmark? Front Endocrinol (Lausanne) 4:99.
44. Yoo KH, Hennighausen L (2012) EZH2 methyltransferase and H3K27 methylation in breast cancer. Int J Biol Sci 8(1):59-65.
45. Du J, et al. (2012) FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells. Breast Cancer Res Treat 131(1):65-73.
46. Miyamoto Y, et al. (2010) Identification of UNC5A as a novel transcriptional target of tumor suppressor p53 and a regulator of apoptosis. Int J Oncol 36(5):1253-1260.
47. Mustafi R, et al. (2012) Both stromal cell and colonocyte epidermal growth factor receptors control HCT116 colon cancer cell growth in tumor xenografts. Carcinogenesis 33(10):1930-1939.
48. Cheng CJ, et al. (2009) SCUBE2 suppresses breast tumor cell proliferation and confers a favorable prognosis in invasive breast cancer. Cancer Res 69(8):3634-3641.
49. Nie DS, Liu Y, Juan H, Yang X (2013) Overexpression of human SPATA17 protein induces germ cell apoptosis in transgenic male mice. Mol Biol Rep 40(2):1905-1910.
50. Lee S, et al. (2012) Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancer. Cancer Res 72(17):4574-4586.
51. Zhang F, et al. (2003) O-GlcNAc modification is an endogenous inhibitor of the proteasome. Cell 115(6):715-725.
52. Kamemura K, Hart GW (2003) Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: a new paradigm formetabolic control of signal transduction and transcription. Prog Nucleic Acid Res Mol Biol 73:107-136.
53. Wu SC, Zhang Y (2011) Cyclin-dependent kinase 1 (CDK1)-mediated phosphorylation of enhancer of zeste 2 (Ezh2) regulates its stability. J Biol Chem 286(32):28511-28519.
54. Wang Z, et al. (2010) Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates cytokinesis. Sci Signal 3(104):ra2.
55. Iyer SP, Hart GW (2003) Roles of the tetratricopeptide repeat domain in O-GlcNAc transferase targeting and protein substrate specificity. J Biol Chem 278(27):24608-24616.
56. Iyer SP, Akimoto Y, Hart GW (2003) Identification and cloning of a novel family of coiled-coil domain proteins that interact with O-GlcNAc transferase. J Biol Chem 278(7):5399-5409.
57. Hosogane M, Funayama R, Nishida Y, Nagashima T, Nakayama K (2013) Ras-induced changes in H3K27me3 occur after those in transcriptional activity. PLoS Genet 9(8): e1003698.
58. Klymenko T, et al. (2006) A Polycomb group protein complex with sequence-specific DNA-binding and selective methyl-lysine-binding activities. Genes Dev 20(9):1110-1122.
59. Shi-Chen Ou D, et al. (2011) Transcriptional activation of endoplasmic reticulum chaperone GRP78 by HCMV IE1-72 protein. Cell Res 21(4):642-653.